Surprisingly, in neither of these two studies did the authors explore the relationship between RhoA and PKC in terms of their activation of MARCKS nor their possible downstream effects on the invasion, migration and metastatic capacities of BRAFi-R melanoma cells. The gene discussed is MARCKS; the disease is melanoma.